EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Bioswitchable miRNA Mimic Delivery System: Therapeutic Strategies Upgraded from Tetrahedral Framework Nucleic Acid System for Fibrotic Disease Treatment and Pyroptosis Pathway Inhibition

Yueying Jiang, Songhang Li, Ruijianghan Shi, Wumeng Yin, Weitong Lv, Taoran Tian, Yunfeng Lin iD

Advanced Science · 2024

DOI: 10.1002/advs.202305622 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Yueying Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China Hospital of S…. Hauptthemen laut MEDLINE: Nucleic Acids, MicroRNAs. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Sichuan Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There has been considerable interest in gene vectors and their role in regulating cellular activities and treating diseases since the advent of nucleic acid drugs. MicroRNA (miR) therapeutic strategies are research hotspots as they regulate gene expression post‐transcriptionally and treat a range of diseases. An original tetrahedral framework nucleic acid (tFNA) analog, a bioswitchable miR inhibitor delivery system (BiRDS) carrying miR inhibitors, is previously established; however, it remains unknown whether BiRDS can be equipped with miR mimics. Taking advantage of the transport capacity of tetrahedral framework nucleic acid (tFNA) and upgrading it further, the treatment outcomes of a traditional tFNA and BiRDS at different concentrations on TGF‐β‐ and bleomycin‐induced fibrosis simultaneously in vitro and in vivo are compared. An upgraded traditional tFNA is designed by successfully synthesizing a novel BiRDS, carrying a miR mimic, miR‐27a, for treating skin fibrosis and inhibiting the pyroptosis pathway, which exhibits stability and biocompatibility. BiRDS has three times higher efficiency in delivering miRNAs than the conventional tFNA with sticky ends. Moreover, BiRDS is more potent against fibrosis and pyroptosis‐related diseases than tFNAs. These findings indicate that the BiRDS can be applied as a drug delivery system for disease treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nucleic AcidsMicroRNAsHumansPyroptosisFibrosisDrug Delivery Systems

Stichwörter der Autor:innen

bioswitchable miR inhibitor delivery systemgene deliverymiRNAspyroptosisskin fibrosistetrahedral framework nucleic acids

Substanzen

Nucleic AcidsMicroRNAs

Autor:innen und Institutionen

  • State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, 610041, China.
  • Sichuan Provincial Engineering Research Center of Oral Biomaterials, Sichuan University, Chengdu, Sichuan, 610041, China.

ORCID-Profile: Yunfeng Lin

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • Sichuan Science and Technology Program
  • Sichuan Province Youth Science and Technology Innovation Team
  • Research and Develop Program, West China Hospital of Stomatology Sichuan University
  • National Key Research and Development Program of China

Zitieren

APA

Jiang, Y., Li, S., Shi, R., Yin, W., Lv, W., Tian, T., & Lin, Y. (2024). A Novel Bioswitchable miRNA Mimic Delivery System: Therapeutic Strategies Upgraded from Tetrahedral Framework Nucleic Acid System for Fibrotic Disease Treatment and Pyroptosis Pathway Inhibition. Advanced Science. https://doi.org/10.1002/advs.202305622

Vancouver

Jiang Y, Li S, Shi R, Yin W, Lv W, Tian T, et al. A Novel Bioswitchable miRNA Mimic Delivery System: Therapeutic Strategies Upgraded from Tetrahedral Framework Nucleic Acid System for Fibrotic Disease Treatment and Pyroptosis Pathway Inhibition. Advanced Science. 2024. doi:10.1002/advs.202305622

BibTeX
@article{Jiang2024,
  author = {Jiang, Yueying and Li, Songhang and Shi, Ruijianghan and Yin, Wumeng and Lv, Weitong and Tian, Taoran and Lin, Yunfeng},
  title = {A Novel Bioswitchable miRNA Mimic Delivery System: Therapeutic Strategies Upgraded from Tetrahedral Framework Nucleic Acid System for Fibrotic Disease Treatment and Pyroptosis Pathway Inhibition},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202305622}
}
Kostenlos starten →